Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases

Tumor Biology

Volumn 28, Issue 5, 2007, Pages 247-252

  Sutnar, A ^a   Pesta, M ^a   Liska, V ^a   Treska, V ^a   Skalicky, T ^a   Kormunda, S ^a   Topolcan, O ^a   Cerny, R ^b   Holubec, L ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Colorectal cancer; Early recurrence; Liver metastases; Liver surgery; Matrix metalloproteinases, inhibitors; Prognostic factors

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GELATINASE B; MATRILYSIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; HOUSEKEEPING GENE; HUMAN; LIVER METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY;

EID: 36448995847     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110897     Document Type: Article

References (28)

1. Bird NC, Mangnall D, Majeed AW: Biology of colorectal liver metastases:a review. J Surg Oncol 2006;94:68-80.
2. Beard SM, Holmes M, Price C, Majeed AW: Hepatic resection for colorectal liver metastases: a cost-effectiveness analysis. Ann Surg 2000;232:763-776.
3. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O: Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003;39:718-727.
4. Fingleton BM, Heppner Goss KJ, Crawford HC, Matrisian LM: Matrilysin in early stage intestinal tumorigenesis. APMIS 1999;107:102-110.
5. Murashige M, Miyahara M, Shiraishi N, Saito T, Kohno K, Kobayashi M: Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol 1996;26:303-309.
6. Baker EA, Bergin FG, Leaper DJ: Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg 2000;87:1215-1221.
7. Pesta M, Holubec L Jr, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R: Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Anticancer Res 2005;25:3387-3391.
8. Gomez DE, Alonso DF, Yoshiji H, Thorgeisson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-122.
9. Cerna M, Holubec L Jr, Pesta M, Kormunda S, Topolcan O, Cerny R: Quantitative estimation of CEA and CK20 expression in tumour tissue of colorectal cancer and its liver metastases with reverse transcription and real-time PCR. Anticancer Res 2006;26:803-808.
10. Chang TJ, Juan CC, Yin PH, Chi CW, Tsay HJ: Up-regulation of beta-actin, cyclophilin and GAPDH in N1S1 rat hepatoma. Oncol Rep 1998;5:469-471.
11. Ripple MO, Wilding G: Alteration of glyceraldehyde-3-phosphate dehydrogenase activity and messenger RNA content by androgen in human prostate carcinoma cells. Cancer Res 1995;55:4234-4236.
12. Miura M, Ichikawa Y, Tanaka K, Kamiyama M, Hamaguchi Y, Ishikawa T, Yamaguchi S, Togo S, Ike H, Ooki S, Shimada H: Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients. Anticancer Res 2003;23:1271-1276.
13. Ho SB, Hyslop A, Albrecht R, Jacobson A, Spencer M, Rothenberger DA, Niehans GA, D'Cunha J, Kratzke RA: Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen. Clin Cancer Res 2004;10:5777-5784.
14. Kijima M, Togo S, Ichikawa Y, Miura M, Yamagishi S, Matsuo K, Tanaka K, Masui H, Ishikawa T, Ike H, Shimada H: Clinical significance of serum CEA protein and CEA mRNA after resection of colorectal liver metastases. Anticancer Res 2005;25:1327-1332.
15. Tien YW, Lee PH, Hu RH, Hsu SM, Chang KJ: The role of gelatinase in hepatic metastasis of colorectal cancer. Clin Cancer Res 2003;9:4891-4896.
16. Heslin MJ, Yan J, Johnson MR, Weiss H, Diasio RB, Urist MM: Role of matrix metalloproteinases in colorectal carcinogenesis. Ann Surg 2001;233:786-792.
17. Waas ET, Wobbes T, Ruers T, Lomme RM, Hendriks T: Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease. Eur J Surg Oncol 2006;32:756-763.
18. Ishida H, Murata N, Tada M, et al: Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer. Jpn J Clin Oncol 2003;33:186-191.
19. Curran S, Dundas SR, Buxton J, et al: Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancer. Clin Cancer Res 2004;10:8229-8234.
20. Adachi Y, Yamamoto H, Itoh F, et al: Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 1999;45:252-258.
21. Leeman MF, Curran S, Murray GI: New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 2003;201:528-534.
22. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR: Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 1991;49:666-672.
23. Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W, Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res 1995;1:899-906.
24. Murashige M, Miyahara M, Shiraishi N, Saito T, Kohno K, et al: Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol 1996;26:303-309.
25. Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brunner N: High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res 2000;6:4292-4299.
26. Yamamoto H, Itoh F, Adachi Y, Fukushima H, Itoh H, Sasaki S, Hinoda Y, Imai K: Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma. Jpn J Clin Oncol 1999;29:58-62.
27. European Group on Tumor Markers: Consensus Recommendations. Anticancer Res 1999;19:2785-2820.
28. Holubec L Jr, Topolcan O, Finek J, Holdenrieder S, Stieber P, Pesta M, Pikner R, Holubec Sen L, Sutnar A, Liska V, Svobodova S, Visokai V, Kormunda S: Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma. Anticancer Res 2005;25:1597-1601.